Autolus
IPOLondon, United Kingdom · Founded 2014 · $183.0M raised
- Headquarters
- London
- Employees
- 201–500
- Founded
- 2014
- Business Model
- B2B
- Total Funding
- $183.0M
- Last Round
- $80.0M Series CSep 2017
- Rounds
- 3
About
Clinical-stage biopharmaceutical company developing next-generation CAR T cell therapies for cancer.
Summary
Autolus is a Biotech company based in London, United Kingdom, founded in 2014. It has raised $183.0M in total across 3 rounds, most recently a $80.0M Series C round in Sep 2017. Investors include Woodford Investment Management, Syncona Partners and GV.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2017
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...